RETRACTED: Probiotics intake and metabolic syndrome: A proposal (Retracted article. See vol. 39, pg. 85, 2014)

被引：7

作者：

Bogsan, Cristina Stewart B. ^{[1
]}

Florence, Ana Carolina R. ^{[1
]}

Perina, Natalia ^{[1
]}

Barbuti, Ricardo C. ^{[2
]}

Navarro-Rodriguez, Tomas ^{[2
]}

Eisig, Jaime N. ^{[2
]}

Oliveira, Marice N. ^{[1
]}

机构：

[1] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Biochem Pharmaceut Technol, BR-05508000 Sao Paulo, Brazil

[2] Univ Sao Paulo, Clin Hosp, Dept Gastroenterol, BR-05508000 Sao Paulo, Brazil

来源：

TRENDS IN FOOD SCIENCE & TECHNOLOGY | 2011年 / 22卷 / 08期

基金：

巴西圣保罗研究基金会;

关键词：

LACTOBACILLUS-GASSERI SBT2055; GUT MICROBIOTA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ADIPOCYTE SIZE; IKK-BETA; OBESITY; DIET; INFLAMMATION; DIVERSITY;

D O I：

10.1016/j.tifs.2011.05.006

中图分类号：

TS2 [食品工业];

学科分类号：

0832 ;

摘要：

Probiotics are practical tools to provide the modulation of microbiota. The ingestion of food or ingredients containing anti-inflammatory activity components as probiotics should be useful in obesity control and associated co-morbidities treatment. Metabolic syndrome is a metabolic dysfunction associated with visceral obesity and insulin resistance, in which the alterations in host microbiota interactions play an important role. Besides diet and physical activity, new strategies are necessary to control metabolic syndrome, and as consequence improving quality of life. This article revises the actual knowledge concerning probiotic intake and obesity as a proposal to control metabolic syndrome.

引用

页码：457 / 464

页数：8

共 70 条

[1] Comparative Analysis of Human Gut Microbiota by Barcoded Pyrosequencing [J].

Andersson, Anders F. ;

Lindberg, Mathilda ;

Jakobsson, Hedvig ;

Backhed, Fredrik ;

Nyren, Pal ;

Engstrand, Lars .

PLOS ONE, 2008, 3 (07)

[2]

[Anonymous], 2002, GUIDELINES EVALUATIO

[3] IKK-β links inflammation to obesity-induced insulin resistance [J].

Arkan, MC ;

Hevener, AL ;

Greten, FR ;

Maeda, S ;

Li, ZW ;

Long, JM ;

Wynshaw-Boris, A ;

Poli, G ;

Olefsky, J ;

Karin, M .

NATURE MEDICINE, 2005, 11 (02) :191-198

[4] Addressing the gut microbiome and implications for obesity [J].

Backhed, Fredrik .

INTERNATIONAL DAIRY JOURNAL, 2010, 20 (04) :259-261

[5]

Bukowska H, 1998, ATHEROSCLEROSIS, V137, P437

[6] Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB [J].

Cai, DS ;

Yuan, MS ;

Frantz, DF ;

Melendez, PA ;

Hansen, L ;

Lee, J ;

Shoelson, SE .

NATURE MEDICINE, 2005, 11 (02) :183-190

[7] Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders [J].

Camilleri, Michael ;

Bueno, Lionel ;

de Ponti, Fabrizio ;

Fioramonti, Jean ;

Lydiard, R. Bruce ;

Tack, Jan .

GASTROENTEROLOGY, 2006, 130 (05) :1421-1434

[8] The gut microbiome as therapeutic target [J].

Cani, Patrice D. ;

Delzenne, Nathalie M. .

PHARMACOLOGY & THERAPEUTICS, 2011, 130 (02) :202-212

[9] Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota [J].

Cani, Patrice D. ;

Delzenne, Nathalie M. .

CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (06) :737-743

[10] The Role of the Gut Microbiota in Energy Metabolism and Metabolic Disease [J].

Cani, Patrice D. ;

Delzenne, Nathalie M. .

CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (13) :1546-1558

← 1 2 3 4 5 6 7 →